Trans-chalcone and quercetin down-regulate fatty acid synthase gene expression and reduce ergosterol content in the human pathogenic dermatophyte Trichophyton rubrum

Tamires Aparecida Bitencourt,Ana Lúcia Fachin,Rene Oliveira Beleboni,Carlos Eduardo Saraiva Miranda,Bruna Gabriele Massaroto,Tatiana Takahasi Komoto,Mozart Marins

doi:10.1186/1472-6882-13-229

Tamires Aparecida Bitencourt, Ana Lúcia Fachin + Show 5 more

Open Access

https://doi.org/10.1186/1472-6882-13-229

Copy DOI

Abstract

BackgroundFatty acid synthase (FAS) is a promising antifungal target due to its marked structural differences between fungal and mammalian cells. The aim of this study was to evaluate the antifungal activity of flavonoids described in the scientific literature as FAS inhibitors (quercetin, trans-chalcone, ellagic acid, luteolin, galangin, and genistein) against the dermatophyte Trichophyton rubrum and their effects on fatty acid and ergosterol synthesis.MethodsThe antifungal activity of the natural products was tested by the microdilution assay for determination of the minimum inhibitory concentration (MIC). The effect of the compounds on the cell membrane was evaluated using a protoplast regeneration assay. Ergosterol content was quantified by spectrophotometry. Inhibition of FAS by flavonoids was evaluated by an enzymatic assay to determine IC50 values. Quantitative RT-PCR was used to measure transcription levels of the FAS1 and ERG6 genes involved in fatty acid and ergosterol biosynthesis, respectively, during exposure of T. rubrum to the flavonoids tested.ResultsThe flavonoids quercetin and trans-chalcone were effective against T. rubrum, with MICs of 125 and 7.5 μg/mL for the wild-type strain (MYA3108) and of 63 and 1.9 μg/mL for the ABC transporter mutant strain (ΔTruMDR2), respectively. The MICs of the fluconazole and cerulenin controls were 63 and 125 μg/mL for the wild-type strain and 30 and 15 μg/mL for the mutant strain, respectively. Quercetin and trans-chalcone also reduced ergosterol content in the two strains, indicating that interference with fatty acid and ergosterol synthesis caused cell membrane disruption. The MIC of quercetin reduced the number of regenerated protoplasts by 30.26% (wild-type strain) and by 91.66% (mutant strain). Half the MIC (0.5 MIC) of quercetin did not reduce the number of regenerated wild-type fungal colonies, but caused a 36.19% reduction in the number of mutant strain protoplasts. In contrast, the MIC and 0.5 MIC of trans-chalcone and cerulenin drastically reduced protoplast regeneration in the two strains. The FAS1 gene was repressed in the presence of MICs of quercetin, trans-chalcone, fluconazole and cerulenin. The ERG6 gene was induced in the presence of MICs of fluconazole and cerulenin and was repressed in the presence of MICs of trans-chalcone and quercetin. Trans-chalcone and quercetin inhibited the enzymatic activity of FAS, with IC50 values of 68.23 and 17.1 μg/mL, respectively.ConclusionTrans-chalcone and quercetin showed antifungal activity against T. rubrum, reducing ergosterol levels and modulating the expression of FAS1 and ERG6.

Highlights

Fatty acid synthase (FAS) is a promising antifungal target due to its marked structural differences between fungal and mammalian cells
We explored the antifungal activity of quercetin and five other flavonoids described as inhibitors of FAS against T. rubrum [12]
We evaluated the antifungal activity of flavonoids against T. rubrum and their effects on fatty acid and ergosterol synthesis using a wild-type strain and a mutant strain (ΔTruMDR2) that carries a disrupted version of an ABC transporter involved in multidrug resistance [15]

Summary

Introduction

Fatty acid synthase (FAS) is a promising antifungal target due to its marked structural differences between fungal and mammalian cells. The main etiological agent of dermatophytosis is the anthropophilic and cosmopolitan fungus Trichophyton rubrum, which accounts for 69.5% of all dermatophytic infections [2,3] Infections caused by this species are difficult to treat and there is only a limited number of antifungal drugs available for clinical use, especially when compared to the arsenal of antibacterial drugs [4,5]. An interesting target is fatty acid synthase (FAS), an enzyme that participates in endogenous fatty acid synthesis [9] The fact that this enzyme shows marked structural differences between fungal and mammalian cells makes it a promising target for the development of new antifungal drugs [10]. This compound covalently binds to the catalytic site of FAS and disrupts the condensation reaction of acetyl-COA and malonyl-COA, inhibiting the biosynthesis of fatty acids and sterols in yeast [11]

Objectives

Methods

Results

Discussion

Conclusion